Loading
Latest filing published 22 Jun 2016 for Alexza Pharmaceuticals Inc., €15.6M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Grupo Ferrer Internacional, S.A. discloses dealings in Alexza Pharmaceuticals Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 28 September 2015 to 21 June 2016.
Every open-market trade on record is a purchase: 3 purchases worth €15.6M, and no sale. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2016: 2 purchases and no sales on the market.
On 22 June 2016 came the latest disclosure, an open-market purchase for €15.6M in Alexza Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations